Abstract
Background: Millions of patients present annually with chest pain, but only 10% have myocardial infarction (MI). We recently reported comparative sensitivity and specificity of available markers in the diagnosis of MI; however, optimum interpretation of marker results requires prognostic follow‐up data.
Hypothesis: The study was undertaken to study the accuracy of CK‐MB subforms, troponin I and T, myoglobin, and CK‐MB in predicting clinical events at 30 days and 6 months.
Methods: in all, 955 consecutive patients with chest pain were enrolled in a prospective, multicenter, double‐blind study to test the prognostic accuracy of these markers.
Results: Myocardial infarction was diagnosed in 119 by CK‐MB mass criteria and unstable angina (UA) in 203 patients by clinical criteria. Follow‐up at 30 days and 6 months was available in 824 and 724 patients, respectively, with mortalities of 2.8 and 4.14%, respectively. Cumulative 6‐month mortality was 5.6% in MI, 4.4% in UA, and 3.0% in others. Revascularization was reported in 9.3% of patients by 6 months. A positive test on each of the markers except myoglobin was predictive of revascularization. The composite endpoint of death or revascularization occurred in 107 patients by 6 months and a positive result on each of the markers was predictive of this composite endpoint (p < 0.05). The relative risk of death or revascularization for patients who did not have MI but tested positive on each of the markers was > 1.0 but did not reach statistical significance.
Conclusions: With the possible exception of myoglobin, each of the diagnostic markers displayed similar prognostic performance in patients with chest pain presenting to emergency departments. The most appropriate markers to triage patients with chest pain, which has both adequate early diagnostic sensitivity and prognostic accuracy, are the CK‐MB subforms.
Keywords: diagnostic markers, prognosis, creatine kinase‐MB, troponin I, troponin T, myoglobin
Full Text
The Full Text of this article is available as a PDF (469.5 KB).
References
- 1. Fisch C: The Clinical Electrocardiogram: Sensitivity and Specificity In ACC Current Journal Review, p. 71–75 (Ed. Fisch C.). New York: Elsevier Science, Inc., 1997. [Google Scholar]
- 2. Zimmerman J, Fromm R, Meyer D, Boudreaux A, Wun C‐C, Smalling RW, David B, Habib G, Roberts R: Diagnostic marker cooperative study (DMCS) for the diagnosis of myocardial infarction. Circulation 1999; 99 (13): 1671–1677 [DOI] [PubMed] [Google Scholar]
- 3. The DRG Handbook : Comparative Clinical and Financial Standards, 1998. Baltimore, Md: HCIA, 1998. [Google Scholar]
- 4. Puleo PR, Meyer D, Wathen C, Tawa CB, Wheeler SH, Hamburg RJ, Ali MN, Obermueller SD, Triana JT, Zimmerman JL, Perryman MB, Roberts R: Use of rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction. N Engl J Med 1994; 331: 561–566. [DOI] [PubMed] [Google Scholar]
- 5. Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW, O'Hanesian MA, Wagner GS, Kleiman NS, Harrell FE Jr, Califf RM, Topol EJ: Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med 1996; 335: 1333–1341. [DOI] [PubMed] [Google Scholar]
- 6. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, Fischer GA, Fung AY, Thompson C, Wybenga D, Braunwald E: Cardiac‐specific troponin I used to predict die risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996, 335: 1342–1349 [DOI] [PubMed] [Google Scholar]
- 7. McCarthy BD, Beshansky RJ, D'Agostino RB, Selker HP: Missed diagnoses of acute myocardial infarction in the emergency department: Results from a multicenter study. Ann Emerg Med 1993; 22: 579–582. [DOI] [PubMed] [Google Scholar]
- 8. Lee TH, Rouan GW, Weisberg MC, Brand DA, Acampora D, Stasiulewicz C, Walshon J, Terranova G, Gottlieb L, Goldstein‐Wayne B, Copen D, Daley K, Brandt AA, Mellors J, Jakubowski R, Cook EF, Goldman L: Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. Am J Cardiol 1987; 60: 219–224. [DOI] [PubMed] [Google Scholar]
- 9. Braunwald E, Mark DB, Jones RH, Cheitlin MD, Fuster V, McCauley KM, Edwards C, Green LA, Mushlin AI, Swain JA, Smith EE, III , Cowan M, Rose GC, Concannon CA, Grines CL, Brown L, Lytle BW, Goldman L, Topol EJ, Willerson JT, Brown J, Archibald N: Unstable Angina: Diagnosis and Management. Washington, D.C.: AHCPR Publication No. 94–0602, 1994.
- 10. de Winter RJ, Koster RW, Schotveld JH, Sturk A, van Straalen IP, Sanders GT: Prognostic value of troponin T, myoglobin, and CK‐MB mass in patients presenting with chest pain without acute myocardial infarction. Heart 1996; 75: 235–239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Braunwald E, Maseri A, Armstrong PW, Califf RM, Gibler WB, Hamm CW, Simoons ML, Van de Werf F: Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes. Eur Heart J 1998; 19:D22–D30 [PubMed] [Google Scholar]
- 12. Boden WE, O'Rourke RA, Crawford MH, Glaustein AS, Deed‐wania PC, Zoble RG, Wexler LF, Kleiger RE, Pepine CJ, Ferry DR, Chow BK, Lavori PW: Outcomes in patients with acute non‐Q‐wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. VA Non‐Q‐Wave Infarction Strategies in Houston (VANQWISH) Trial. N Engl J Med 1998; 338: 1785–1792. [DOI] [PubMed] [Google Scholar]